Yüklüyor......
Case of drug-induced interstitial lung disease secondary to adalimumab
We report a rare case of drug-induced intestinal lung disease (ILD) secondary to adalimumab, a tumour necrosis factor alpha-receptor blocker. A 52-year-old smoker with ankylosing spondylitis, treated with adalimumab, presented with progressive breathlessness. A high resolution CT chest demonstrated...
Kaydedildi:
| Yayımlandı: | BMJ Case Rep |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5965751/ https://ncbi.nlm.nih.gov/pubmed/29764848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224375 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|